文献速递血管炎

简报:抗中性粒细胞胞质抗体相关血管炎患者的循环细胞因子谱与抗中性粒细胞胞质抗体特异性

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
PubMed 文献 · Arthritis Rheumatol · 2018-05-07

在186例活动性AAV患者中检测29种细胞因子,按ANCA特异性(PR3-ANCA vs MPO-ANCA)或临床诊断(GPA vs MPA)分组比较。结果显示PR3-AAV与MPO-AAV间有9种和4种细胞因子分别升高,GPA与MPA间有6种和3种分别升高;多变量分析中8种细胞因子按ANCA特异性分组区分患者优于按临床诊断分组,提示循环免疫介质差异与ANCA特异性关联更强。

要点

  • PR3-AAV较MPO-AAV有9种细胞因子显著升高,MPO-AAV较PR3-AAV有4种升高(均P<0.05)。
  • GPA较MPA有6种细胞因子显著升高,MPA较GPA有3种升高(均P<0.05)。
  • 多数细胞因子在PR3-AAV与MPO-AAV间的差异大于GPA与MPA间的差异。

核心结论

  • PR3-AAV与MPO-AAV之间以及GPA与MPA之间均存在不同的循环细胞因子谱。
  • 这些循环免疫介质的差异与ANCA特异性的关联强于与临床诊断的关联,提示AAV亚型的异质性超出临床表型。

研究设计与样本

  • 在纳入Rituximab in AAV试验的186例活动性AAV患者中检测29种细胞因子。
  • 在每个分类系统内比较组间细胞因子浓度,并进行校正年龄、性别和肾功能不全的多变量分析,以每种生物标志物为因变量,以ANCA特异性和临床诊断为感兴趣的 explanatory 变量。

主要发现

  • PR3-AAV较MPO-AAV显著升高的9种细胞因子为IL-6、GM-CSF、IL-15、IL-18、CXCL8/IL-8、CCL-17/TARC、IL-18 BP、sIL-2Rα和NGFβ(均P<0.05)。
  • MPO-AAV较PR3-AAV显著升高的4种细胞因子为sIL6R、sTNFRII、NGAL和sICAM-1(均P<0.05)。
  • GPA较MPA显著升高的6种细胞因子为IL-6、GM-CSF、IL-15、IL-18、sIL-2Rα和NGFβ(均P<0.05)。
  • MPA较GPA显著升高的3种细胞因子为骨桥蛋白、sTNFRII和NGAL(均P<0.05)。
  • 多变量分析显示8种细胞因子(IL-15、IL-8、IL-18 BP、NGF-β、sICAM-1、TARC、骨桥蛋白和肾损伤分子1,P<0.05)按ANCA特异性分组时区分AAV患者优于按临床诊断分组(P值更低、效应量更大)。

关键数值与推荐

  • PR3-AAV与MPO-AAV比较:9种细胞因子在PR3-AAV更高,4种在MPO-AAV更高(均P<0.05)。
  • GPA与MPA比较:6种细胞因子在GPA更高,3种在MPA更高(均P<0.05)。
  • 多变量分析中8种细胞因子以ANCA特异性分组时区分AAV患者优于以临床诊断分组(P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate circulating cytokine profiles in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV), classified by antineutrophil cytoplasmic antibody (ANCA) specificity (proteinase 3 ANCA [PR3-ANCA] versus myeloperoxidase ANCA [MPO-ANCA]) or by clinical diagnosis (granulomatosis with polyangiitis [GPA] versus microscopic polyangiitis [MPA]). METHODS: A panel of 29 cytokines was tested in 186 patients with active AAV at inclusion into the Rituximab in AAV trial. Cytokine concentrations were compared between groups within each classification system. Multivariable analyses adjusted for age, sex, and renal insufficiency were performed, with each biomarker as a dependent variable and ANCA specificity and clinical diagnosis as explanatory variables of interest. RESULTS: Levels of 9 circulating cytokines (interleukin-6 [IL-6], granulocyte-macrophage colony-stimulating factor [GM-CSF], IL-15, IL-18, CXCL8/IL-8, CCL-17/thymus and activation-regulated chemokine [TARC], IL-18 binding protein [IL-18 BP], soluble IL-2 receptor α [sIL-2Rα], and nerve growth factor β [NGFβ]) were significantly higher in PR3-AAV than MPO-AAV, 4 cytokines (sIL6R, soluble tumor necrosis factor receptor type II [sTNFRII], neutrophil gelatinase-associated lipocalin [NGAL], and soluble intercellular adhesion molecule 1 [sICAM-1]) were higher in MPO-AAV than in PR3-AAV, 6 cytokines (IL-6, GM-CSF, IL-15, IL-18, sIL-2Rα, and NGFβ) were higher in GPA than in MPA, and 3 cytokines (osteopontin, sTNFRII, and NGAL) were higher in MPA than in GPA (all P < 0.05). For nearly all cytokines, the difference between PR3-AAV and MPO-AAV was larger than that between GPA and MPA. The multivariate analysis showed that 8 cytokines (IL-15, IL-8, IL-18 BP, NGF-β, sICAM-1, TARC, osteopontin, and kidney injury molecule 1 (P < 0.05) distinguished patients with AAV better (lower P values and larger effect sizes) when grouped by ANCA specificity than by clinical diagnosis. CONCLUSION: Distinct cytokine profiles were identified for PR3-AAV versus MPO-AAV and for GPA versus MPA. Differences in these circulating immune mediators are more strongly associated with ANCA specificity than with clinical diagnosis, suggesting that heterogeneity in the AAV subtypes extends beyond clinical phenotypes.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Berti A, Warner R, Johnson K, et al. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2018. PMID: 29693324. doi:10.1002/art.40471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。